Posts Tagged ‘drug mergers’

Alpharma: Above Buyout Premium on Exponential Volume (ALO, KG)

Alpharma inc. (NYSE: ALO) isn’t exactly your run of the mill “most active” stock, but it is this morning.  King Pharmaceuticals (NYSE: KG) has offered to buy the drug company in a $1.4 Billion buyout valuing the company at $33.00 in cash per share.  Shares are already up over that level at $34.20 after ten [...]

Late After-Hours Spike: Teva/Barr (TEVA, BRL)

We are seeing highly unusual volume trading in Barr Pharmaceuticals Inc. (NYSE: BRL) in late after-hours trading tonight.  The culprit is a report (possible rumor) that Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is in talks to buy the US-generic drug maker. Barr Labs closed up 1.6% today at $46.82, but its market cap at that [...]